Bafnapharm Q3 Results

  • BSE: 532989
  • NSE: BAFNAPH
  • ISIN: INE878I01022
  • Sector: Biotechnology & Drugs
BSE
81.741.74 (2.18%)
Volume51.00
Updated: Mon 25 Nov, 2024 | 15:17:01
NSE
800.00 (0.00%)
Volume137.00
Updated: Mon 25 Nov, 2024 | 15:17:10
Today: 80.10
81.74
52-Wk: 73.35
112.20

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bafnapharm Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 28.4440.68-%34.22-%
    Selling/ General/ Admin Expenses Total 4.534.85-%3.92-%
    Depreciation/ Amortization 1.271.24-%1.40-%
    Other Operating Expenses Total 2.703.03-%2.24-%
    Total Operating Expense 31.7937.92-%32.07-%
    Operating Income -3.352.76-%2.15-%
    Net Income Before Taxes -2.942.48-%2.99-%
    Net Income -2.942.48-%2.99-%
    Diluted Normalized EPS -1.241.05-%1.26-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts